Xinde Hu

2.8k total citations · 1 hit paper
14 papers, 967 citations indexed

About

Xinde Hu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xinde Hu has authored 14 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xinde Hu's work include CRISPR and Genetic Engineering (8 papers), RNA regulation and disease (4 papers) and Retinal Development and Disorders (3 papers). Xinde Hu is often cited by papers focused on CRISPR and Genetic Engineering (8 papers), RNA regulation and disease (4 papers) and Retinal Development and Disorders (3 papers). Xinde Hu collaborates with scholars based in China, United States and Denmark. Xinde Hu's co-authors include Hui Yang, Erwei Zuo, Wei Yu, Yidi Sun, Yixue Li, Haibo Zhou, Changyang Zhou, Linyu Shi, Yajing Liu and Rui Yan and has published in prestigious journals such as Nature, Nature Cell Biology and Developmental Cell.

In The Last Decade

Xinde Hu

14 papers receiving 955 citations

Hit Papers

Off-target RNA mutation induced by DNA base editing and i... 2019 2026 2021 2023 2019 100 200 300

Peers

Xinde Hu
Ramu Gopalappa South Korea
Jarryd M. Campbell United States
Kraig M. Theriault United States
Jennifer M. Cherone United States
Joshua B. Black United States
Adrienn Volak United States
Ramu Gopalappa South Korea
Xinde Hu
Citations per year, relative to Xinde Hu Xinde Hu (= 1×) peers Ramu Gopalappa

Countries citing papers authored by Xinde Hu

Since Specialization
Citations

This map shows the geographic impact of Xinde Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinde Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinde Hu more than expected).

Fields of papers citing papers by Xinde Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinde Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinde Hu. The network helps show where Xinde Hu may publish in the future.

Co-authorship network of co-authors of Xinde Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinde Hu. A scholar is included among the top collaborators of Xinde Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinde Hu. Xinde Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zhang, Liansheng, Zhengzheng Xu, Zhiheng Jia, et al.. (2025). Modulating mTOR-dependent astrocyte substate transitions to alleviate neurodegeneration. Nature Aging. 5(3). 468–485. 13 indexed citations
2.
Zhang, Liansheng, Zhiheng Jia, Qiang Wu, et al.. (2023). Alleviating symptoms of neurodegenerative disorders by astrocyte-specific overexpression of TMEM164 in mice. Nature Metabolism. 5(10). 1787–1802. 18 indexed citations
3.
Liu, Fei, Shiqi Xu, Qiang Wu, et al.. (2022). An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines. Vaccine. 40(9). 1208–1212. 4 indexed citations
4.
Gao, Ni, Jing Hu, Bingbing He, et al.. (2021). Endogenous promoter-driven sgRNA for monitoring the expression of low-abundance transcripts and lncRNAs. Nature Cell Biology. 23(1). 99–108. 13 indexed citations
5.
Ling, Sikai, Shiqi Yang, Xinde Hu, et al.. (2021). Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice. Nature Biomedical Engineering. 5(2). 144–156. 135 indexed citations
6.
Xue, Yuanyuan, Xinde Hu, Daqi Wang, et al.. (2021). Gene editing in a Myo6 semi-dominant mouse model rescues auditory function. Molecular Therapy. 30(1). 105–118. 51 indexed citations
7.
Zhou, Changyang, Xinde Hu, Cheng Tang, et al.. (2020). CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration. National Science Review. 7(5). 835–837. 43 indexed citations
8.
Zhou, Changyang, Yidi Sun, Rui Yan, et al.. (2019). Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis. Nature. 571(7764). 275–278. 343 indexed citations breakdown →
9.
Hu, Xinde, Jinghan Wang, Xuan Yao, et al.. (2019). Screened AAV variants permit efficient transduction access to supporting cells and hair cells. Cell Discovery. 5(1). 49–49. 31 indexed citations
10.
Hu, Xinde, Yifeng Liu, Ping Ai, et al.. (2019). MicroRNA‑186 promotes cell proliferation and inhibits cell apoptosis in cutaneous squamous cell carcinoma by targeting RETREG1. Experimental and Therapeutic Medicine. 17(3). 1930–1938. 11 indexed citations
11.
Yao, Xuan, Meiling Zhang, Xing Wang, et al.. (2018). Tild-CRISPR Allows for Efficient and Precise Gene Knockin in Mouse and Human Cells. Developmental Cell. 45(4). 526–536.e5. 108 indexed citations
12.
Zuo, Erwei, Xuan Yao, Xinde Hu, et al.. (2017). CRISPR/Cas9-mediated targeted chromosome elimination. Genome biology. 18(1). 224–224. 139 indexed citations
13.
Yao, Xuan, Xing Wang, Junlai Liu, et al.. (2017). CRISPR/Cas9 – Mediated Precise Targeted Integration In Vivo Using a Double Cut Donor with Short Homology Arms. EBioMedicine. 20. 19–26. 56 indexed citations
14.
Zhou, Yang, Mingxun Li, Xinde Hu, et al.. (2017). Characterization of candidate genes for bovine adipogenesis reveals differences of TUSC5 isoforms caused by novel alternative splicing. Oncotarget. 0(0). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026